# The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

> **NCT06236022** · PHASE4 · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 276 (estimated)

## Conditions studied

- Dilated Cardiomyopathy
- Kaposi's Sarcoma-Associated Herpesvirus Infection

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT06236022
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2024-02-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06236022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06236022, "The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06236022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*